We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+5.62%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$262M
AUM Growth
+$10.7M
Cap. Flow
+$4.02M
Cap. Flow %
1.54%
Top 10 Hldgs %
69.6%
Holding
162
New
14
Increased
11
Reduced
9
Closed
31
Avg Time Held
1.2 years
Top 10 Avg Time Held
1.3 years
Top 20 Avg Time Held
1 year

Top Buys

Rank Stock Value
1
DCGO icon
DocGo
DCGO
+$4.26M
2
CLOZ icon
Panagram BBB-B CLO ETF
CLOZ
+$3.14M
3
GCVRZ
Sanofi Contingent Value Rights
GCVRZ
+$3M
4
MOR icon
MorphoSys AG American Depositary Shares
MOR
+$2.66M
5
UTHR icon
United Therapeutics
UTHR
+$2.06M

Top Sells

Rank Stock Value
1
AGAC.WS
African Gold Acquisition Corp Warrants
AGAC.WS
+$5.18M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$3.42M
3
SNY icon
Sanofi
SNY
+$3.02M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$2.8M
5
FIP icon
FTAI Infrastructure
FIP
+$1.57M

Sector Composition

Rank Sector Weight
1 Materials 34.61%
2 Healthcare 25.56%
3 Financials 13.62%
4 Miscellaneous 7.72%
5 Industrials 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CLMT icon
1
Calumet Specialty Products
CLMT
$5.06B
$87.4M 33.37%
4,576,000
– –
2021 Q4
7 quarters
APO icon
2
Apollo Global Management
APO
$67B
$20.2M 7.71%
225,000
– –
2021 Q4
7 quarters
FTAI icon
3
FTAI Aviation
FTAI
$16.8B
$15.1M 5.77%
425,000
– –
2021 Q4
7 quarters
GOOG icon
4
Alphabet (Google) Class C
GOOG
$4.2T
$14.8M 5.65%
112,220
– –
2021 Q4
7 quarters
DCGO icon
5
DocGo
DCGO
$26.9M
$10.3M 3.92%
1,925,000
+525,000
+38% +$4.26M
2021 Q4
7 quarters
MDWT
6
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$10.2M 3.9%
390,241
– –
2021 Q4
7 quarters
LGND icon
7
Ligand Pharmaceuticals
LGND
$5.88B
$6.89M 2.63%
115,000
– –
2021 Q4
7 quarters
ARDX icon
8
Ardelyx
ARDX
$824M
$6.12M 2.34%
1,500,000
– –
2022 Q3
4 quarters
MITAW icon
9
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$5.69M 2.17%
495,000
– –
2021 Q4
7 quarters
OABI icon
10
OmniAb
OABI
$662M
$5.64M 2.15%
1,086,505
– –
2022 Q4
3 quarters
FBRT icon
11
Franklin BSP Realty Trust
FBRT
$500M
$4.34M 1.66%
327,524
-101,523
-24% -$1.41M
2021 Q4
7 quarters
SGEN
12
DELISTED
Seagen Inc. Common Stock
SGEN
$3.82M 1.46%
18,000
+1,500
+9% +$300K
2023 Q1
2 quarters
PFE icon
13
Pfizer
PFE
$166B
$3.23M 1.24%
97,537
– –
2021 Q4
7 quarters
CLOZ icon
14
Panagram BBB-B CLO ETF
CLOZ
$785M
$3.16M 1.21%
+121,032
New +$3.14M
2023 Q3
0 quarters
JPM icon
15
JPMorgan Chase
JPM
$890B
$3.04M 1.16%
20,985
– –
2021 Q4
7 quarters
GCVRZ
16
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3M 1.15%
+56,000
New +$3M
2023 Q3
0 quarters
JAZZ icon
17
Jazz Pharmaceuticals
JAZZ
$13.6B
$2.9M 1.11%
22,411
– –
2021 Q4
7 quarters
CHRS icon
18
Coherus Oncology
CHRS
$162M
$2.36M 0.9%
630,000
+384,990
+157% +$1.78M
2023 Q2
1 quarter
GSK icon
19
GSK
GSK
$95.9B
$2.36M 0.9%
65,000
– –
2022 Q3
4 quarters
MOR icon
20
DELISTED
MorphoSys AG American Depositary Shares
MOR
$2.32M 0.89%
+345,000
New +$2.66M
2023 Q3
0 quarters
AVDL
21
DELISTED
Avadel Pharmaceuticals
AVDL
$2.29M 0.87%
221,850
-18,779
-8% -$252K
2021 Q4
7 quarters
MDGL icon
22
Madrigal Pharmaceuticals
MDGL
$10.6B
$2.19M 0.84%
15,000
+1,000
+7% +$188K
2022 Q3
4 quarters
CSX icon
23
CSX Corp
CSX
$89.4B
$2.15M 0.82%
70,000
– –
2022 Q4
3 quarters
VKTX icon
24
Viking Therapeutics
VKTX
$3.24B
$2.05M 0.78%
185,555
+110,006
+146% +$1.57M
2021 Q4
7 quarters
UTHR icon
25
United Therapeutics
UTHR
$23.2B
$2.02M 0.77%
+8,949
New +$2.06M
2023 Q3
0 quarters
1
2 3 4 5

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q3 2023 Portfolio in Review

As of Q3 2023, David M. Knott Jr held 162 positions worth $262M, up 4.2% from $251M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

David M. Knott Jr's Q3 2023 filing shows 14 new, 11 increased, 9 reduced and 31 closed positions. Its largest new stake was Panagram BBB-B CLO ETF: 121,032 shares worth $3.16M. The largest sale was African Gold Acquisition Corp Warrants, an estimated $5.18M.

By sector, the portfolio is most concentrated in Materials at 35% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • David M. Knott Jr's largest Q3 2023 buy was Panagram BBB-B CLO ETF: 121,032 shares worth $3.16M.
  • David M. Knott Jr added most to DocGo in Q3 2023, an estimated $4.26M increase.
  • David M. Knott Jr's biggest Q3 2023 reduction was Seres Therapeutics, cutting an estimated $1.53M.
  • David M. Knott Jr fully exited African Gold Acquisition Corp Warrants in Q3 2023, selling an estimated $5.18M.
  • David M. Knott Jr's ten largest holdings make up 70% of its $262M portfolio in Q3 2023.
  • David M. Knott Jr opened 14 new positions and closed 31 in Q3 2023.
  • David M. Knott Jr's portfolio value rose 4.2% quarter-over-quarter to $262M.

Based on David M. Knott Jr's 13F filing for Q3 2023, filed 13 Nov 2023.